Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$20.64 - $25.45 $1.61 Million - $1.99 Million
-78,024 Reduced 44.88%
95,841 $2.05 Million
Q4 2023

Feb 09, 2024

BUY
$21.06 - $27.57 $1.18 Million - $1.54 Million
55,944 Added 47.44%
173,865 $4.18 Million
Q3 2023

Nov 13, 2023

BUY
$27.56 - $35.7 $154,611 - $200,277
5,610 Added 5.0%
117,921 $3.29 Million
Q2 2023

Aug 10, 2023

BUY
$31.53 - $39.74 $2.57 Million - $3.24 Million
81,446 Added 263.88%
112,311 $3.8 Million
Q1 2023

May 09, 2023

BUY
$32.84 - $42.5 $1.01 Million - $1.31 Million
30,865 New
30,865 $1.26 Million
Q3 2020

Nov 12, 2020

SELL
$19.71 - $26.07 $827,149 - $1.09 Million
-41,966 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$12.98 - $24.5 $543,329 - $1.03 Million
-41,859 Reduced 49.94%
41,966 $885,000
Q1 2020

May 13, 2020

BUY
$11.91 - $33.2 $998,355 - $2.78 Million
83,825 New
83,825 $1.25 Million

Others Institutions Holding NVST

About Envista Holdings Corp


  • Ticker NVST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 163,391,008
  • Market Cap $3.41B
  • Description
  • Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment...
More about NVST
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.